Third Rock Forms Global Blood Therapeutics, Kicks in $40.7MByVCJ Staff14 June 2012•5 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.FundraisingManagersNorth AmericaUSFundraisingBriefs